San Diego, California, January 21, 2026
Crown Bioscience has announced that its San Diego laboratory has received accreditation from the College of American Pathologists (CAP). This significant milestone enhances its clinical-grade biomarker testing capabilities and builds on its existing CLIA certification. The accreditation ensures compliance with federal standards for clinical testing, thus enabling better support for regulated drug development programs. This advancement positions Crown Bioscience as a trusted partner for biotechnology and pharmaceutical companies in advancing oncology and precision medicine initiatives.
San Diego, California – Crown Bioscience’s San Diego Laboratory Achieves CAP Accreditation, Enhancing Clinical-Grade Capabilities
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced that its San Diego laboratory has achieved accreditation from the College of American Pathologists (CAP). This milestone builds upon the laboratory’s Clinical Laboratory Improvement Amendments (CLIA) certification obtained in July 2025, further strengthening its ability to deliver clinical-grade biomarker testing to support regulated drug development programs.
Significance of CAP Accreditation
CAP accreditation is recognized as a leading benchmark for laboratory quality, reflecting rigorous standards for operational excellence, technical competence, and quality oversight. Together with CLIA certification—regulated by the U.S. Centers for Medicare & Medicaid Services—these credentials confirm the San Diego laboratory’s compliance with federal requirements for clinical testing on human specimens and its readiness to support biomarker analyses aligned with clinical trial and regulatory expectations.
Implications for Drug Development
With these accreditations, Crown Bioscience’s San Diego laboratory enables closer integration of biomarker testing across preclinical and clinical workflows, supporting continuity of data and alignment with regulatory requirements throughout development. This achievement further strengthens Crown Bioscience’s growing global network of accredited and certified laboratories, reinforcing its role as a trusted partner to biotechnology and pharmaceutical companies advancing oncology and precision medicine programs.
About Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology. We partner with biotech and pharmaceutical companies to provide innovative, tailored solutions spanning preclinical research, translational platforms, and clinical trial support. With the world’s largest commercially available patient-derived xenograft (PDX) collection and approximately 1,000 tumor organoid models powered by Hubrecht Organoid Technology, we offer unparalleled insights across 35 cancer indications. Our expertise spans in vivo, in vitro, ex vivo, and in silico methods, complemented by advanced laboratory services that span the entire drug development continuum. Additionally, our extensive biobank of liquid and human biospecimens, complete with clinical histories, enhances oncology research capabilities. Operating from 11 state-of-the-art facilities across the US, Europe, and APAC, our laboratories meet the highest industry standards, including accreditation by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO). To learn more, visit www.crownbio.com.
Frequently Asked Questions (FAQ)
What is CAP accreditation?
CAP accreditation is a leading benchmark for laboratory quality, reflecting rigorous standards for operational excellence, technical competence, and quality oversight. It confirms a laboratory’s compliance with federal requirements for clinical testing on human specimens and its readiness to support biomarker analyses aligned with clinical trial and regulatory expectations.
What is CLIA certification?
CLIA certification, regulated by the U.S. Centers for Medicare & Medicaid Services, confirms a laboratory’s compliance with federal requirements for clinical testing on human specimens. It ensures that laboratories meet quality standards for testing and reporting results.
How do CAP accreditation and CLIA certification benefit Crown Bioscience’s San Diego laboratory?
These accreditations enable the San Diego laboratory to deliver clinical-grade biomarker testing, supporting regulated drug development programs. They also allow for closer integration of biomarker testing across preclinical and clinical workflows, ensuring data continuity and alignment with regulatory requirements throughout development.
What is the significance of these accreditations for Crown Bioscience?
Achieving CAP accreditation and CLIA certification strengthens Crown Bioscience’s global network of accredited and certified laboratories, reinforcing its role as a trusted partner to biotechnology and pharmaceutical companies advancing oncology and precision medicine programs.
Key Features of Crown Bioscience’s San Diego Laboratory
| Feature | Description |
|---|---|
| Location | San Diego, California |
| Accreditations | CAP Accreditation, CLIA Certification |
| Capabilities | Clinical-grade biomarker testing, support for regulated drug development programs |
| Integration | Closer integration of biomarker testing across preclinical and clinical workflows |
| Global Network | Part of Crown Bioscience’s global network of accredited and certified laboratories |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE SAN DIEGO WRITER
The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
